Allarity TherapeuticsALLR
13F holders, Q1 2024 (March 31)4holders
$0.30avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Allarity Therapeutics Inc. (ALLR) in their 13F filings. The largest holders were UBS Group AG ($10K), Tower Research Capital LLC (TRC) ($2K) and Wells Fargo & Company ($11).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744302
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $10K |
| Exits | 2 | $29K |
Ownership 4 holders
| UBS Group AG | 0.00% | New | 33,026 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3.3% | 5,721 | $2K |
| Wells Fargo & Company | 0.00% | Add +12.5% | 36 | $11 |
| Morgan Stanley | 0.00% | New | 7 | $2 |
"% of holder's portfolio" is ALLR's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.